Navigation Links
Ohio Becoming Global Hub for Biomedical Research and Commercialization
Date:11/12/2008

BioInnovation Institute combines Ohio's strengths in the polymer industry

and medical fields to spark biomedical innovation

COLUMBUS, Ohio, Nov. 12 /PRNewswire/ -- Ohio aims to become a global hub for biomedical research, commercialization and innovation after the recent launch of the BioInnovation Institute located in Akron, Ohio. According to the Ohio Business Development Coalition, the nonprofit organization that markets the state for capital investment, the BioInnovation Institute will bring together Ohio's world-class organizations, researchers and educators in the polymer industry and biomaterials and biomedical fields to generate the next generation of life-enhancing innovation for the 21st century.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071107/CLW113LOGO )

The result of public-private partnerships from organizations throughout the state, the BioInnovation Institute will create a nationally distinctive center of excellence by drawing talent from across the globe, increase annual funding for Ohio's polymer industry and biomedical research, increase investment by national firms into the state and bring thousands of new jobs to Ohio by 2018.

"The BioInnovation Institute in Akron is uniquely positioned to meld the state's traditional strengths in research and education in both the polymer industry and biomedical excellence to create transformational new technologies with a direct impact on the people we collectively serve," said William H. Considine, chairman of the BioInnovation Institute and president and chief executive officer of Akron Children's Hospital. "Our vision of making Akron, and the state of Ohio, a national leader in the biomedical field is absolutely attainable given our intellectual, educational, research and commercial strengths."

Founders of the BioInnovation Institute include Akron Children's Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM), Summa Health System and The University of Akron. Faculty members will include researchers, physicians and educators from the partner organizations.

The John S. and James L. Knight Foundation led the funding effort to create the BioInnovation Institute with a $20 million grant. Supporting partners have secured $80 million overall for the project. The state of Ohio also has contributed more than $8 million through the Ohio Third Frontier Project, a 10-year, $1.6 billion initiative to help catalyze connections between companies and academia. The project is the state's largest-ever commitment to expanding high-tech research capabilities and promoting innovation and company formation that will create high-paying jobs for generations to come.

"Ohio leads the world in advanced materials capability and is rapidly becoming a global leader in the bioscience industry. The cross fertilization of knowledge between these two industries has the potential to lead to commercial innovations that will dramatically improve lives. It will also stimulate new capital investment in our economy," said Ed Burghard, executive director of the Ohio Business Development Coalition. "Companies are attracted to the bottom-line benefits generated from the superior work-life balance found in Ohio. Ohio's low-cost, low stress communities and combination of micropolitan and metropolitan cities provides executives and employees the resources and time to make any ambition achievable. Ohio truly is the state of perfect balance."

About the Ohio Business Development Coalition

The Ohio Business Development Coalition is a nonprofit organization that markets the state for capital investment. The OBDC provides marketing strategy and implementation to support Ohio's economic development efforts. For more information on business development or business relocation, visit http://www.ohiomeansbusiness.com.


'/>"/>
SOURCE Ohio Business Development Coalition
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Alkemists Sets The Bar, Becoming a 'Green' Analytical Laboratory
2. Calorimeters and Thermal Analysis Equipment Market to Exceed $539 Million by 2012, According to New Report by Global Industry Analysts
3. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
4. New Generation Biofuels CEO to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
6. AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw Annual Global Investment Conference November 12, 2008
7. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
8. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
9. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
10. The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
11. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):